|Articles|February 1, 2003

Multi Passes

Sacramento, Calif. - A multipass technique using a longer interval between pulses may offer new opportunities for therapeutic benefits when treating vascular lesions with a pulsed dye laser, Emil A. Tanghetti, M.D., said.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe

Related Content

Palmoplantar Psoriasis Data Show Zasocitinib Edge Over Apremilast

ByLeon H. Kircik, MD,Kaitlyn Bader, Assistant Managing Editor

August 6th 2026

Compounded Topical Isotretinoin Offers Acne Care Outside iPLEDGE

ByAaron S. Farberg, MD,Shannon Heaning, Content Associate

August 6th 2026

Interim Trial Results and Preclinical Data Highlight Potential of ABS-201 in Androgenetic Alopecia

ByMarie Bosslett, Assistant Editor

August 6th 2026

ICYMI: EU Approves Upadacitinib for Severe Alopecia as US Review Remains Pending

ByMarie Bosslett, Assistant Editor

August 6th 2026

From Wound Care to Aesthetics: How Conexeu Plans to Capitalize on the Bio-Regeneration Market

ByMiles Harrison,Brian Pilcher, PhD,Marie Bosslett, Assistant Editor

August 5th 2026

Latest CME

Video

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Adaptive Learning

Medical Crossfire®: Navigating Chronic GVHD Prophylaxis and Treatment – Targeted Strategies to Elevate Patient Outcomes

Corey Cutler, MD, MPH, FRCP(C); Amin M. Alousi, MD; Mehdi Hamadani, MD; Anna Sureda, MD, PhD

Multi Passes

Related Content

Palmoplantar Psoriasis Data Show Zasocitinib Edge Over Apremilast

Compounded Topical Isotretinoin Offers Acne Care Outside iPLEDGE

Interim Trial Results and Preclinical Data Highlight Potential of ABS-201 in Androgenetic Alopecia

ICYMI: EU Approves Upadacitinib for Severe Alopecia as US Review Remains Pending

From Wound Care to Aesthetics: How Conexeu Plans to Capitalize on the Bio-Regeneration Market

Latest CME

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Medical Crossfire®: Navigating Chronic GVHD Prophylaxis and Treatment – Targeted Strategies to Elevate Patient Outcomes

Trending on Dermatology Times

AAD Pediatric AD Guidelines Back Roflumilast, Ruxolitinib, Tapinarof

FDA Accepts sBLA for OnabotulinumtoxinA in Masseter Muscle, Pursuing Fifth Aesthetic Indication

ICYMI: EU Approves Upadacitinib for Severe Alopecia as US Review Remains Pending

Zasocitinib Shows High Rates of Scalp Psoriasis Clearance Through Week 24

From Wound Care to Aesthetics: How Conexeu Plans to Capitalize on the Bio-Regeneration Market